Stockscreener 앱 받기
4.06
2.78%
0.11
전일 마감가:
$3.95
열려 있는:
$3.9
하루 거래량:
24,873
Relative Volume:
0.55
시가총액:
$28.27M
수익:
$7.00M
순이익/손실:
$-70.79M
주가수익비율:
-0.419
EPS:
-9.69
순현금흐름:
$-64.34M
1주 성능:
+2.27%
1개월 성능:
-8.76%
6개월 성능:
-32.89%
1년 성능:
-33.58%
1일 변동 폭
$3.90
$4.0831
1주일 범위
$3.84
$4.0831
52주 변동 폭
$3.6201
$9.18
Kezar Life Sciences Inc Stock (KZR) Company Profile
명칭
Kezar Life Sciences Inc
전화
650-822-5600
주소
4000 SHORELINE COURT, SUITE 300, SOUTH SAN FRANCISCO, CA
KZR을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
KZR
Kezar Life Sciences Inc
|
4.06 | 28.27M | 7.00M | -70.79M | -64.34M | -9.69 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.12 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
589.48 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.38 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
660.00 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
313.67 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Kezar Life Sciences Inc Stock (KZR) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2023-08-11 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2023-03-16 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2021-12-08 | 개시 | Wells Fargo | Overweight |
| 2018-07-16 | 개시 | Jefferies | Buy |
| 2018-07-16 | 개시 | Wells Fargo | Outperform |
| 2018-07-16 | 개시 | William Blair | Outperform |
모두보기
Kezar Life Sciences Inc 주식(KZR)의 최신 뉴스
Forecasting Kezar Life Sciences Inc. price range with options dataTrade Analysis Report & Short-Term Trading Opportunity Alerts - Newser
Live market analysis of Kezar Life Sciences Inc.Quarterly Trade Summary & Consistent Profit Trading Strategies - Newser
What does recent volatility data suggest for Kezar Life Sciences Inc.July 2025 Market Mood & Risk Managed Investment Strategies - Newser
Smart tools for monitoring Kezar Life Sciences Inc.’s price actionPortfolio Return Report & Weekly High Conviction Trade Ideas - Newser
Should you wait for a breakout in Kezar Life Sciences Inc.Market Activity Recap & Long-Term Growth Portfolio Plans - Newser
What the charts say about Kezar Life Sciences Inc. todayTrade Risk Summary & Detailed Earnings Play Alerts - Newser
Short interest data insights for Kezar Life Sciences Inc.July 2025 Snapshot & Stock Portfolio Risk Control - Newser
Is this a good reentry point in Kezar Life Sciences Inc.Earnings Trend Report & Weekly Return Optimization Alerts - Newser
What to do if you’re stuck in Kezar Life Sciences Inc.Earnings Overview Report & Real-Time Buy Zone Alerts - Newser
What earnings revisions data tells us about Kezar Life Sciences Inc.Quarterly Risk Review & Weekly Top Gainers Trade List - Newser
Is Kezar Life Sciences Inc. stock entering bullish territoryPortfolio Performance Report & Long-Term Investment Growth Plans - Newser
William Blair Brokers Boost Earnings Estimates for KZR - Defense World
Real time social sentiment graph for Kezar Life Sciences Inc.Quarterly Trade Report & Smart Swing Trading Techniques - Newser
Is Kezar Life Sciences Inc. stock reversal real or fakeQuarterly Portfolio Summary & Smart Allocation Stock Tips - Newser
Technical Bounce Expected in Kezar Life Sciences Inc. Next WeekMarket Performance Report & High Win Rate Trade Alerts - classian.co.kr
Main Inc. stock outlook for YEARJuly 2025 Volume & Comprehensive Market Scan Reports - Newser
What candlestick patterns are forming on Kezar Life Sciences Inc.July 2025 Levels & AI Based Buy and Sell Signals - Newser
How Kezar Life Sciences Inc. stock reacts to Fed policy changesTrade Performance Summary & Safe Swing Trade Setups - Newser
Is Kezar Life Sciences Inc. likely to announce a buybackJuly 2025 Big Picture & Fast Exit and Entry Strategy Plans - thegnnews.com
Kezar Life Sciences Inc. Recovery Likely Here’s What Data ShowsValue Driven Trading Forecast Strategy - beatles.ru
Wells Fargo Keeps Their Hold Rating on Kezar Life Sciences (KZR) - The Globe and Mail
Is it too late to sell Kezar Life Sciences Inc.Trend Reversal & Stepwise Trade Execution Plans - Newser
Should you hold or exit Kezar Life Sciences Inc. nowQuarterly Portfolio Report & Breakout Confirmation Trade Signals - Newser
How to escape a deep drawdown in SoundHound AI Inc. Equity WarrantWeekly Stock Recap & Free Expert Verified Stock Movement Alerts - Newser
Should you hold or exit Sprouts Farmers Market Inc. nowJuly 2025 Spike Watch & Capital Protection Trading Alerts - Newser
Using AI based signals to follow Arrowhead Pharmaceuticals Inc.Weekly Trading Summary & Fast Gaining Stock Reports - Newser
Detecting support and resistance levels for Kezar Life Sciences Inc.July 2025 Big Picture & High Return Stock Watch Alerts - Newser
Can technical indicators confirm Kezar Life Sciences Inc.’s reversalWeekly Earnings Recap & Accurate Intraday Trading Signals - Newser
How to use a screener to detect Kezar Life Sciences Inc. breakoutsJuly 2025 Patterns & Stock Market Timing Techniques - Newser
How Kezar Life Sciences Inc. stock performs during market volatilityMarket Sentiment Summary & Free Weekly Chart Analysis and Trade Guides - Newser
Can Kezar Life Sciences Inc. ride the EV wave2025 Market Overview & High Accuracy Investment Entry Signals - sundaytimes.kr
Kezar Life Sciences' Positive Trial Results and Regulatory Progress Boost Buy Rating - AInvest
Positive Phase 2 Trial Results and Regulatory Progress Bolster Buy Rating for Kezar Life Sciences - TipRanks
Kezar Life Sciences Advances in Autoimmune Hepatitis Trials - TipRanks
Kezar Life Sciences Inc (KZR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Kezar Life Sciences Inc 주식 (KZR) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Schiller Mark C. | Chief Operating Officer |
Jul 02 '25 |
Sale |
4.28 |
561 |
2,401 |
2,739 |
0.94%
1.72%
자본화:
|
볼륨(24시간):